A chemical and pharmaceutical manufacturing and distribution company in the USA approached Freyr to file promotional material, protocol amendment, and safety reports with the US FDA. The client was challenged to work on significant volumes of documents in a defined time. Freyr streamlined end-to-end publishing activities from study document preparation to final ESG submission and delivered the submission within very stringent timelines.

Download the case study to learn how Freyr provided the client with compliant submissions free of errors and warnings while delivering the submission on time.